- Title
- Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease Results of the PIONEER III Randomized Clinical Trial
- Creators
- Alexandra J. Lansky - Queen Mary University of LondonDean J. Kereiakes - Christ HospitalAndreas Baumbach - Queen Mary University of LondonStephan Windecker - University Hospital of BernYasin Hussain - Yale UniversityCody Pietras - Yale UniversityOvidiu Dressler - Cardiovascular Research FoundationOzgu Issever - Cardiovascular Research FoundationMichael Curtis - University of CalgaryBarry Bertolet - North Mississippi Medical CenterNabil Dib - Celebration Stem Cell Centreet al.
- Publication Details
- Circulation (New York, N.Y.), Vol.143(22), pp.2143-2154
- Number of pages
- 12
- Grant note
- National Institute for Health Research Barts Cardiovascular Biomedical Research Center Abbott Vascular (http://data.elsevier.com/vocabulary/SciValFunders/100011949) Medtronic (http://data.elsevier.com/vocabulary/SciValFunders/100004374) Cordis (http://data.elsevier.com/vocabulary/SciValFunders/100006479) Siemens Medical Technologies St. Jude Medical (http://data.elsevier.com/vocabulary/SciValFunders/100006279) Biosensors International Group (http://data.elsevier.com/vocabulary/SciValFunders/501100008877) Biomenco Spain Boston Scientific Corporation (http://data.elsevier.com/vocabulary/SciValFunders/100008497)
- Identifiers
- 991006261161302656
- Academic Unit
- Cardiology
- Language
- English
- Resource Type
- Journal article
Journal article
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease Results of the PIONEER III Randomized Clinical Trial
Circulation (New York, N.Y.), Vol.143(22), pp.2143-2154
06/01/2021
PMID: 33820424
Metrics
1 Record Views